Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
-59.2%/yr
Long-term compound
Percentile
P38
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $320000.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $28.30M | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $30.42M | +55.0% |
| 2017 | $19.62M | +670.1% |
| 2016 | $2.55M | - |